Articles
A Strong Partnership in Drug Development – How CDMOs and Consultants Mutually Benefit Their Clients
The field of drug development can be risky and a costly investment - mistakes can mean the success or failure of a compound or even a company. And, while demands for specialized treatments and therapies continues to surge around...
Articles
What is the Internet of Behaviours (IoB) and why Pharma and Health Brands should be paying attention
The Internet of Things (IoT) has been the topic of discussion for many years in the technology and data circles. However, the Internet cannot exist without people and what they do with it. This has led to a line...
Articles
A key decision in sterile manufacturing: Choosing the right CDMO partner
Contamination of drug substances and drug products leads to a risk of harm. This risk is particularly high in drugs delivered via the intravenous or ophthalmic routes, as these drugs bypass many of the body’s natural defenses. The development...
Articles
How innovation and responsibility contribute to patient’s well-being
In the health care industry, changes are occurring at a rapid pace. People, machines, and information are becoming even more interconnected. Meanwhile, unanticipated events such as the Covid-19 pandemic affect the pharma and biotech industry as well. To meet...
Articles
Antibiotic powders : Maximum safety and efficiency during filling
Pharmaceutical powders form the basis for numerous antibiotics that are essential for comprehensive medical care. However, margins are low and production conditions are complex. What kind of equipment and support do drug manufacturers and contract manufacturers need to make...
Articles
Ayushman Bharat Digital Mission: The Benefit and Future of Digitisation in the Medical Sciences
The current Ayushman Bharat Digital Mission by the PM to allow greater IT-penetration of healthcare is welcome news. What makes it doubly so, is the focus on digital health such as app-based solutions. This is because leveraging digital technology...
Articles
A Collaborative Effort Paves the Way for a New Approach to Small Batch Manufacturing
In today’s pharmaceutical industry there is a sharp focus on the needs and requirements of the patient. More and more drugs are being developed for specific patient groups.Orphan drugs, for example,may require small batch sizes ranging anywhere from 500...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.